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OBJECTIVES The goal of this study was to determine the prevalence of depression in an out-patient heart
failure (HF) population; its relationship to quality of life (QOL); and the impact of gender,
race, and age.
BACKGROUND Most studies of depression in HF have evaluated hospitalized patients (a small percentage of
the population) and have ignored the influence of various patient characteristics. Although
reported depression rates among hospitalized patients range from 13% to 77.5%, out-patient
studies have been small, have reported rates of 13% to 42%, and have not adequately
accounted for the impact of age, race, or gender.
METHODS A total of 155 patients with stable New York Heart Association functional class II, III, and
IV HF and an ejection fraction 40% were given questionnaires to assess QOL and
depression. These included the Medical Outcomes Study Short Form, the Minnesota Living
with Heart Failure questionnaire, and the Beck Depression Inventory (BDI). Depression was
defined as a score on the BDI of 10.
RESULTS A total of 48% of the patients scored as depressed. Depressed patients tended to be younger than
non-depressed patients. Women were more likely (64%) to be depressed than men (44%). Among
men, blacks (34%) tended to have less depression than whites (54%). Depressed patients scored
significantly worse than non-depressed patients on all components of both the questionnaires
measuring QOL. However, they did not differ in ejection fraction or treatment, except that
depressed patients were significantly less likely to be receiving beta-blockers.
CONCLUSIONS Depression is common in patients with HF, with age, gender, and race influencing its prevalence
in ways similar to those observed in the general population. These data suggest that pharmacologic
or non-pharmacologic treatment of depression might improve the QOL of HF patients. (J Am
Coll Cardiol 2004;43:1542–9) © 2004 by the American College of Cardiology Foundationp
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tany factors appear to affect the prevalence of depression in
atients with chronic disease. The nature of the underlying
isease, the treatment administered, when the patient is
ssessed, social support, gender, race, and age all may affect
sychological status. Thus, up to 46% of cancer patients
ave been reported to meet criteria for depression (1), and
6% of males and 47% of females are estimated to have
epression after a myocardial infarction (MI) (2).
See page 1550
Congestive heart failure (HF) is a common chronic condi-
ion that affects both genders, all races, and people in various
ge groups. It is estimated to be present in greater than five
illion Americans (3) and accounts for more than 20 billion
ollars in medical care annually (4). Yet most studies of
epression in HF have evaluated hospitalized patients (a small
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Manuscript received September 11, 2003; revised manuscript received October 2,l003, accepted October 21, 2003.ercentage of the population) and have ignored the influence
f various patient characteristics. Although reported depression
ates among hospitalized patients range from 13% to 77.5%
5–8), out-patient studies have been small, have reported rates
f 13% to 42%, and have not adequately accounted for the
mpact of age, race, or gender (9–11).
Depression may have an important effect on many quality of
ife (QOL) aspects in patients with HF. In these patients,
epression is associated with more frequent hospital admis-
ions, a decline in activities of daily living, and worse New York
eart Association (NYHA) functional classification (6,11,12).
he presence of depression in HF patients has been associated
ith increased medical costs (13). It has even been reported
hat depressed patients have higher mortality rates (7).
Because of the potential importance of depression in the
OL of patients with HF and the lack of information about its
revalence, we sought to determine the prevalence of depres-
ion in an unselected out-patient HF clinic population. We
articularly wanted to assess the importance of race, age, and
ender on the frequency of depression and to ascertain the
elationship between depression and QOL measurements.
erhaps by understanding these relationships, the question as
o how often HF leads to depression, or whether depression
eads to perception of worse HF, can be illuminated.
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atients with stable NYHA functional class II, III, and IV
F were recruited for this study from an out-patient
cademic HF practice between December 2000 and De-
ember 2001. All patients had an ejection fraction of 40%
ocumented by nuclear ventriculography or echocardiogra-
hy and did not have an acute exacerbation of symptoms.
one of the participants had HF due to thyroid disease, a
ecent acute MI, or unstable angina. None of the partici-
ants was pregnant. Patients were approached at the con-
lusion of a normal office visit and were asked to participate
n the study; informed consent was obtained.
Each participant completed a questionnaire to provide
emographic information, including age, race, gender, liv-
ng situation, and current medications. Patients’ charts were
eviewed to ascertain co-morbid medical conditions,
YHA functional class, and measured ejection fraction.
urvey questionnaires to assess QOL and depression were
hen filled out by the patient. These were done in private,
xcept for patients who were unable to read the question-
aire. In those patients, a nurse or physician read the form
o the patient.
orms. Quality of life was assessed with two tools, the
edical Outcomes Study Short Form (SF-36) and the
innesota Living with Heart Failure Questionnaire (ML-
HF). The SF-36 was used to obtain information about
eneral QOL, while the MLWHF was used to obtain
nformation specifically about the effect of HF on QOL.
epression was assessed with the Beck Depression Inven-
ory (BDI).
The SF-36 was designed for use in clinical practice and
esearch, health policy evaluations, and general population
urveys. It is designed to assess QOL in persons 14 years
nd older. It includes 36 questions that assess health in eight
ubscales: 1) physical activity limitations; 2) social activity
imitations; 3) usual role activity physical limitations; 4)
odily pain; 5) general mental health (psychological distress
nd well-being); 6) usual role activities emotional limita-
ions; 7) vitality (energy and fatigue); and 8) general health
erceptions (14). The SF-36 shows high test-retest reliabil-
ty, with a reliability coefficient 0.75 for all dimensions
xcept social functioning and is able to distinguish between
Abbreviations and Acronyms
BDI  Beck Depression Inventory
CI  confidence interval
HF  heart failure
MI  myocardial infarction
MLWHF  Minnesota Living With Heart Failure
questionnaire
NYHA  New York Heart Association
OR  odds ratio
QOL  quality of life
SF-36  Medical Outcomes Study Short Formroups with expected health differences. The SF-36 was wble to detect low levels of ill health in patients who had
cored 0 (good health) on the Nottingham health profile
15). Use of the SF-36 has also been validated in an elderly
opulation (16). Standardized scores on the SF-36 scales
ere used for all computations and analyses.
The MLWHF questionnaire is designed to assess the
ffect of HF on QOL. It consists of 21 questions to measure
he effect of symptoms that are specifically related to HF
nd its treatment in adults (17). Two subscales—physical
nd emotional—are identified. Both have high test-retest
eliability (0.89, 0.93, respectively). Total score has been
hown to improve with active medication, compared with
o improvement in a placebo group. Changes in MLWHF
cores over three months correspond well with changes in
atients’ rating of shortness of breath and fatigue (18).
Depression was assessed with the BDI. The BDI is the
ost widely used tool for self-assessment of depression in
linical research. The BDI is short, simple, and easy to
dminister. It consists of 21 items, each with four response
ptions, and it has a reading level of approximately fifth
rade. The scale is intended to rate severity of depression in
ndividuals age 13 years and older. Internal consistency of
he scale is high (0.86 to 0.88 among psychiatric patients
nd 0.81 with non-psychiatric subjects). There is ample
vidence of construct and concurrent validity; BDI and
linical ratings of depression among psychiatric samples
ere highly correlated in meta-analyses. The BDI scores
lso were moderately to highly correlated with scores on the
innesota Multiphasic Personality Inventory Depression,
ung Self Rating Depression, Hopelessness, and Hamilton
cales (19). Depression was defined as a score on the BDI of
10.
tatistics. Chi-square or t tests were used to examine
ifferences in demographic characteristics, illness severity,
ealth history, and QOL between patients who were and
ere not depressed. Pearson correlation coefficients were
sed to examine the relationships of age and left ventricular
jection fraction with degree of depression. Correlations
ere also used to examine the relationships between depres-
ion score and QOL. Stepwise, hierarchical logistic regres-
ion was used to assess the usefulness of demographic,
edical characteristic, and QOL factors in predicting which
atients scored as depressed and to examine whether QOL
ontributed to prediction of depression status beyond the
ontributions of the other factors.
ESULTS
ubjects. A total of 155 patients participated in the study
nd completed study forms. Table 1 includes a summary of
he demographic and medical characteristics of the patients.
atients ranged in age from 33 to 85 years (mean, 64  12
ears), and 79% were men. There were slightly more blacks
han whites. Left ventricular ejection fraction varied from
0% to 40% (mean, 24  7%), and over half of the patients
ere classified as NYHA functional class III. Slightly fewer
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Depression in CHF May 5, 2004:1542–9han one-half had coronary artery disease, and approxi-
ately one-third had diabetes mellitus. A majority of the
atients were being treated with diuretics, digoxin,
ngiotensin-converting enzyme inhibitors, and beta-
lockers. Only 11 patients (7%) were receiving an antide-
ressant medication. A total of 26% of the patients lived
lone.
requency of depression. In this unselected population,
8% of the HF out-patients scored as depressed, as assessed
ith the BDI. Scores on the BDI ranged from 0 to 43
mean, 12  9). Approximately one-sixth of the patients
ere severely depressed, as shown by markedly elevated BDI
Table 1. Comparison of Demographic and He
Heart Failure According to Depression Status,
or Non-Depressed Patients Who Exhibited Th
All Patients
(n  155)
Age 64  12
Ejection fraction 24  7
NYHA class
II 55 (36%)
III 91 (59%)
IV 9 (6%)
Race
Black 89 (57%)
White 65 (42%)
Chinese 1 (1%)
Gender
Men 122 (79%)
Women 33 (21%)
Medications
Diuretics 131 (85%)
Digoxin 130 (84%)
ACE inhibitor 124 (80%)
Beta-blocker 102 (66%)
Angiotensin receptor blocker 24 (16%)
Medical history
Coronary artery disease 72 (46%)
Diabetes 59 (38%)
Hypertension 51 (33%)
Myocardial infarction 37 (24%)
CABG 23 (15%)
Stroke 6 (4%)
PTCA 5 (3%)
PVD 4 (3%)
Coronary artery disease 72 (46%)
Living situation
Lives alone 40 (26%)
Education
9 yrs 17 (11%)
9 to 12 yrs 25 (16%)
High school graduate 52 (34%)
Some college 25 (16%)
College graduate 18 (12%)
Depression status
BDI 10 80 (52%)
BDI 10 to 19 48 (31%)
BDI 19 27 (17%)
*p  0.05 (two-tailed).
ACE  angiotensin-converting enzyme; BDI  Beck De
NYHA  New York Heart Association; PTCA  percutane
disease.cores. The distribution of scores on the BDI is shown in oigures 1 and 2. Among the HF patients with a BDI 10,
he mean BDI score was 19  8. The demographic,
edication, and medical history, as well as the disease
everity characteristics, of the depressed and non-depressed
atients are compared in Table 1.
ge. Patients with BDI  10 tended to be younger than
on-depressed patients (t [140.84]  1.69, p  0.086).
sing a median split of age (64, 64), younger patients
ad worse QOL on the entire MLWHF scale, as well as
n both the emotional and physical subscales, than older
atients (Table 2). Younger patients also had worse
odily pain, mental health, and general functioning than
Status Characteristics of the Patients With
n  SD, or Frequency and (%) of Depressed
haracteristic
Depressed
(n  75)
Non-Depressed
(n  80) p Value
62  14 65  11 0.086
25  7 24  7 0.970
19 (25.3%) 36 (45%) 0.038*
51 (68%) 40 (50%)
5 (6.7%) 4 (5%)
40 (53.3%) 49 (65.3%) 0.344
35 (46.7%) 30 (40%)
0 1 (1.2%)
54 (72%) 68 (85%) 0.048*
21 (41.2%) 12 (15%)
65 (86.7%) 66 (82.5%) 0.474
64 (85.3%) 66 (82.5%) 0.632
60 (80%) 64 (80%) 1.0
43 (57.3%) 59 (73.8%) 0.031*
13 (17.3%) 11 (13.8%) 0.538
26 (34.7%) 33 (41.2%) 0.787
32 (42.7%) 19 (23.8%) 0.399
16 (21.3%) 21 (26.2%) 0.012*
13 (17.3%) 10 (12.5%) 0.502
4 (5.3%) 2 (2.5%) 0.378
2 (2.7%) 3 (3.8%) 0.352
2 (2.7%) 2 (2.5%) 0.703
1 (1.3%) 1 (1.2%) 0.937
26 (34.7%) 33 (41.2%) 0.787
18 (24%) 22 (36.7%) 0.619
7 (9.3%) 10 (12.5%) 0.232
11 (14.7%) 14 (17.5%)
28 (37.3%) 24 (30%)
15 (20%) 10 (12.5%)
5 (6.7%) 13 (16.2%)
n Inventory; CABG  coronary artery bypass graft surgery;
nsluminal coronary angioplasty; PVD  peripheral vascularalth
Mea
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May 5, 2004:1542–9 Depression in CHForrelated with the scores on the MLWHF scales and
ith the bodily pain subscale of the SF-36 (Table 3).
ace and gender. Frequency of BDI  10 did not differ
etween blacks (53%) and whites (47%) (chi-square [n 
54]  1.19, p  0.275).
Women with HF were more likely (64%) to score as
epressed than men (44%) (chi-square [n  155, 1 df] 
.9, p  0.048). The mean BDI was 15  11 for women
nd 11  9 for men (p  0.030).
Among men, blacks (34%) tended to score as depressed
ess frequently than whites (54%) (chi-square [n  121, df
1]  3.14, p  0.077), while among women there was a
on-significant trend, with blacks (70%) scoring as de-
ressed more than whites (54%) (chi-square [n  33, 1 df]
0.89, p  0.35).
nfluence of other factors. There was no difference in the
revalence of BDI 10 among those who lived alone and
hose who lived with others, or according to educational
tatus.
There was no significant difference between those who
cored as depressed and those who did not, regarding use of
iuretics, digoxin, angiotensin-converting enzyme inhibi-
ors, or angiotensin receptor blockers (Table 1). However,
epressed patients were significantly less likely to be receiv-
ng beta-blockers (chi-square [n  155, 1 df]  4.64, p 
.031).
Patients scoring as depressed had a higher prevalence of
ypertension than those who did not (chi-square [n  155,
df]  6.27, p  0.012) but did not differ in history of
oronary artery disease, diabetes mellitus, MI, coronary
rtery bypass surgery, stroke, prior coronary angioplasty, or
eripheral vascular disease.
Frequency of BDI 10 differed significantly according to
YHA functional class (chi-square [n  155, 2 df]  6.51,
 0.038). Patients classified as NYHA functional class III
igure 1. The relationship between extent of depression, as measured by
he Beck Depression Inventory (BDI), and the severity of functional
imitations, as measured by the Minnesota Living With Heart Failure
uestionnaire, in 155 patients with chronic heart failure. r  0.64, p 
.001.nd IV were more likely to score as depressed than class II oatients, but class III and IV patients did not differ from
ach other in frequency of depression. Ejection fraction did
ot differ between patients scoring as depressed and those
ho did not (t [153]  0.64, p  0.95).
epression status and QOL. Depressed patients scored
ignificantly worse than non-depressed patients on all com-
onents of both the measures of QOL. Tables 4 and 5
ompare scores of the depressed and non-depressed patients
as determined by the BDI) on the SF-36 and the ML-
HF scales, respectively.
Severity of depression correlated with severity of impairment
n QOL as measured on both questionnaires. Figure 1 shows
he relationship between the depression score on the BDI and
he MLWHF total score. Correlation coefficients for the BDI
core and other QOL scores are listed in Table 3.
Neither severity of depression nor QOL scale scores
orrelated with ejection fraction (Table 3).
redication of depression status. Stepwise, hierarchical
ogistic regression was used to assess the usefulness of
emographic, medical characteristic, and QOL factors at
redicting which patients scored as depressed. A hierarchi-
al approach was used to force patient demographic factors
nd disease severity factors into the analysis before examin-
ng the contributions of QOL scale scores to patients’
ikelihood of having depressive symptoms. The demo-
raphic factors were entered on the first step (chi-square [3]
10.84, p  0.013). In the first analysis, gender (Wald [1]
4.0, p 0.045; odds ratio [OR] 0.424, 95% confidence
nterval [CI]  0.183 to 0.983) and age (Wald [1]  4.09,
 0.043; OR  1.03, 95% CI  1.001 to 1.06), but not
ace, (Wald [1]  2.87, p  0.101; OR  0.749, 95% CI
0.531 to 1.058) were significant predictors of depression
tatus. Using a classification table with a cutoff of 0.5, the
odel correctly predicted depression status in 58.9% of the
ases. The second step added NYHA functional class to the
odel (chi-square [1]  7.18, p  0.007). In this analysis,
YHA functional classification was a two-level variable (II;
igure 2. Distribution of scores on the Beck Depression Inventory (BDI)
n 155 patients with chronic heart failure.r III and IV). The NYHA functional classification made a
s
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Depression in CHF May 5, 2004:1542–9ignificant contribution to prediction of depression status
Wald [1]  6.87, p  0.009; OR  0.386, 95% CI 
.186 to 0.784). The improved model correctly predicted
he depression status of 62.9% of the patients. The final step
nvolved the addition of the QOL measures to the two
receding steps. Adding the vitality subscale of the SF-36
ade a significant additional contribution (chi-square [1]
1.94, p  0.001) to the prediction of depression status
ased on the preceding model. Vitality was a significant
redictor of depressive symptoms (Wald [1]  18.624, p 
.001; OR  1.079, 95% CI  1.042 to 1.117). The five
redictor variables were simultaneously entered into a logis-
ic regression model (chi-square [5]  39.96, p  .001).
he model predicted depression status correctly in 73% of
he patients. However, only vitality and age made significant
ontributions to the model. Therefore, a final model using
nly age and vitality was computed (chi-square [2] 35.64,
 0.001). This model correctly predicted depression
tatus in 74% of the patients—74% of those who were
Table 2. Mean ( SD) Scores on the SF-36 S
(Age 64 Years) and Older (Age 64 Years)
Age <64 Years
(n  74)
SF-36 subscale
Physical functioning 31.8 (11.9)
Role–physical 34.8 (11.4)
Bodily pain 40.4 (12.5)
General health 33.2 (11.3)
Vitality 42.9 (11.7)
Social functioning 39.7 (13.2)
Role–emotional 38.9 (13.3)
Mental health 44.6 (15.0)
MLWHF scale
Total 46.0 (27.72)
Emotional component 8.9 (8.0)
Physical component 20.1 (12.6)
Note, a higher score on the Medical Outcomes Study Short
Minnesota Living With Heart Failure questionnaire (MLW
able 3. Correlation Coefficients of Quality of Life Measures
ith Depression Score, Age, and Left Ventricular EF
BDI EF Age
LWHF
Total score 0.641* 0.028 0.269*
Physical 0.561* 0.076 0.226*
Emotional 0.730* 0.008 0.171*
F-36
Physical functioning 0.274* 0.077 0.023
Role–physical 0.455* 0.128 0.013
Bodily pain 0.142‡ 0.063 0.215†
General health 0.379* 0.026 0.136
Vitality 0.458* 0.064 0.089
Social functioning 0.336* 0.033 0.068
Role–emotional 0.321* 0.022 0.043
Mental health 0.394* 0.008 0.146
igher score on BDI is more depressed, higher score on MLWHF score is more
mpaired, higher score on Medical Outcomes Study Short Form (SF-36) is better
unctioning. *p  0.001, †p  0.05, ‡p 0.10.aEF  ejection fraction. Other abbreviations as in Tables 1 and 2.epressed, and 73% of those who were not depressed. Being
ounger (Wald [1]  2.89, p  0.09; OR  1.026; 95% CI
0.996 to 1.056) and having worse vitality (lower scores on
he vitality subscale of the SF-36) (Wald [1]  24.66, p 
.001; OR 1.09, 95% CI 1.023 to 1.056) are predictive
f having depressive symptoms. Thus, for every 10 years
bove the mean age, the likelihood of exhibiting depressive
ymptoms decreases by 26%, and for every 10 points below
he mean vitality score, the patient’s likelihood of having
epressive symptoms increases by 90% (almost doubles).
ISCUSSION
revalence of depression. The present study demonstrates
hat depression is extremely common in the HF population,
ith 48% of respondents scoring as depressed. While
revious studies have reported high prevalence of depression
n hospitalized HF patients (5–8,20), this is the largest
tudy to look at out-patients with chronic HF. The high
roportion of patients scoring as depressed is surprising.
he small patient studies have generally reported depression
ates of between 13% and 42% (9–11).
The present study suggests that depression is common in
F patients, but the exact frequency is certainly affected by
ultiple factors related to the nature of the study. For
xample, it was performed in an academic center. In
ddition, the BDI cutoff of 10 was designed to be sensitive.
ertainly, some patients scoring as depressed would not
eet other definitions of depression. This has been previ-
usly seen (7).
The high prevalence of depression in HF patients is
onsistent with previous reports of other chronic diseases. In
he general population, major depression has been reported
o be common in individuals with chronic medical illnesses.
he prevalence of depression is even directly related to the
umber of chronic diseases for a given individual. In
atients with more than two chronic conditions (i.e., severe
ales and the MLWHF Scales for Younger
rt Failure Patients
Age >64 Years
(n  78) t (df) p Value
32.4 (1.4) 0.3 (150) 0.74
35.0 (1.3) 0.1 (150) 0.90
45.5 (1.4) 2.5 (149) 0.015
36.9 (1.4) 2.0 (150) 0.053
45.7 (1.4) 1.4 (150) 0.15
42.9 (1.6) 1.4 (150) 0.15
41.1 (1.6) 1.0 (149) 0.32
50.2 (1.4) 2.5 (150) 0.014
32.7 (24.0) 3.2 (150) 0.002
6.1 (6.5) 2.3 (140.8) 0.022
15.6 (14.4) 2.0 (150) 0.042
(SF-36) indicates better functioning; a higher score on the
ndicates increased disruption of life.ubsc
Hea
Formrthritis, chronic obstructive pulmonary disease, hyperten-
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May 5, 2004:1542–9 Depression in CHFion, diabetes, MI, end-stage renal disease, and cancer), the
revalence of major depression was 12.5% (21). The Diag-
ostic and Statistical Manual of Mental Disorders-Fourth
dition (DSM-IV-text revision) states that approximately
0% to 25% of people with general medical conditions will
ecome depressed during the course of their chronic con-
ition (22).
ender. Although women in the general population are
ore likely to experience depression, there have been no
ublications on the effect of gender on depression in HF
atients. This is a crucial issue because women in the
eneral population have more severe depressive episodes
ith increased functional impairments and are more likely
o develop chronic depression than men (23–26). Even in a
eneral population, 2.6% of males and 7% of females score
s depressed (27). In the present study, consistent with that
een in the general population, women had significantly
orse depression scores than men. This difference tended to
e significant even after controlling for age or other factors.
Our finding that women score as having worse QOL is
onsistent with a small prior study in HF. That study
howed that, despite controlling for age, ejection fraction,
nd NYHA functional classification, women with HF had
orse QOL scores than men (28). Physicians should there-
ore be particularly cognizant of the potential impact of
epression in women with congestive HF.
ace. The present study showed that, overall, black and white
atients with HF did not significantly differ in depression rates.
owever, black men scored as less depressed than white men,
able 4. Mean ( SD) Scores on the SF-36 Subscales for Depre
SF-36 Subscale Concept Measured
hysical functioning Level of physical activity
ole–physical Work limitations due to physical problems
odily pain Degree of bodily pain
eneral health Current health outlook
itality Energy level and well-being
ocial functioning Impact of health problems on social functionin
ole–emotional Work limitations due to emotional problems
ental health Anxiety, depression, well-being, and loss of co
higher score on the Medical Outcomes Study Short Form (SF-36) indicates bette
Table 5. Mean ( SD) Scores on the MLWH
Heart Failure Patients
Depress
Patien
(n  7
Total MLWHF 54  2
Physical component of MLWHF 12  8
Emotional component of MLWHF 25  1
A higher score on the scales indicates increased disruption o
MLWHF  Minnesota Living With Heart Failure questionnahile black women had a non-significantly higher rate of
epression than white women. The Epidemiologic Catchment
rea and National Comorbidity Survey studies of mental
ealth care demonstrated that, in the general population,
lacks are less likely to be affected by major depression than
hites (29). However, they are consistent with the present
tudy in demonstrating that prevalence rates were higher
mong black females than black males.
The difference in prevalence between white and black
en with HF is consistent with the observation that blacks
tilize out-patient mental health services at approximately
ne-half the rate of whites. Social barriers, including stigma,
hysician mistrust, concerns about anti-depressant medica-
ions, and beliefs about the etiology of depression might
ontribute to better scores on depression surveys, a de-
reased incidence of a diagnosis of depression, and a
ifferent utilization rate of mental health services (30).
There has been limited work evaluating the relationship
etween race and depression in the HF population. One
rior study looked at racial differences in depression in 60
ospitalized HF patients. It found that 17% of patients had
ajor depression, and all of these patients were white.
lthough major depression was more common among
hite than black patients with HF (31), that study included
ery few black patients, and lack of depression in such a
mall population has limited value.
ge. Depression was seen more commonly among younger
han older patients in the present study. Surprisingly, in the
eneral population, this comparison is evident as well.
and Non-Depressed Heart Failure Patients
Depressed
Patients
(n  73)
Non-Depressed
Patients
(n  79) t (df) p Value
29  10 35  13 3.67 (143.4)  0.001
30  8 39  12 5.4 (134.4)  0.001
40  13 55  13 2.44 (149) 0.016
31  10 38  13 3.83 (141.4)  0.001
39  9 49.7  12 6.2 (150)  0.001
37  11 45  15 3.68 (144.4)  0.001
36  13 44  14 3.33 (149) 0.001
42  11 52  15 4.42 (150)  0.001
tioning.
ubscales for Depressed and Non-Depressed
Depressed
Patients
(n  79) t (df) p Value
25  21 8.1 (150)  0.001
3  4 8.4 (112.3)  0.001
11  10 6.7 (150)  0.001ssed
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Depression in CHF May 5, 2004:1542–9lthough loneliness, diminished health and strength, and
eath of friends might be expected to lead to higher
epression rates in the elderly, depression is more common
n younger individuals than in those over the age of 65. The
revalence of major depression is 5.0% in 19- to 29-year
lds, 7.5% in 30- to 44-year olds, and 1.4% in those 65 years
nd older (32).
The higher incidence of depression in the young suggests
hat depression is due to a larger disparity between the
erception of functional status and the expectation. The
ifferences in the MLWHF scales between older and
ounger patients support this conjecture. In this study
opulation, younger patients report that their HF interferes
ore with total QOL and with both the emotional and
hysical components of the scale. Younger patients also
eport more bodily pain and worse general QOL on the
F-36. This was true even though objective evidence of
ardiac function by ejection fraction was the same in
epressed and non-depressed patients. Coping with the
hysical and emotional limitations caused by HF may be
ore difficult for younger individuals to accept.
Of course, there may be other reasons that older patients
core as less depressed on the BDI. For example, it is
ossible that older individuals are less likely to report
epressive symptoms for cultural reasons or that they have
ore difficulty with self-administered questionnaires for
ognitive reasons.
epression and QOL. In the present study, the presence
f depression was associated with reduced QOL scores. It
annot be excluded that patients with worse HF experience
lower QOL and are subsequently depressed. However, our
rior study of depression in HF patients suggested that
epression leads to a perception of lower QOL (10). We
howed that, although depressed individuals tend to report
orse physical functioning, the objective assessment of
nergy expenditure by cardiopulmonary exercise testing
ctually tended to be better. Indeed, the depressed group
howed less exertion on testing, with a lower respiratory
uotient. Similarly, the mean ejection fraction of the de-
ressed patients was higher.
Other studies also suggest that QOL scores relate poorly to
unctional status. In one study, the 6-min walk test and peak
xygen uptake correlated with only one of the eight QOL
omains (physical functioning). Left ventricular ejection frac-
ion showed no clear association with QOL, with multiple
egression analysis showing that only the subjective NYHA
unctional class was associated with all QOL scales (33).
lthough other studies found that baseline functional status,
ncluding limitation of activities of daily living and dyspnea at
est, was related to depression, reports of these symptoms are
ubjective, and objective evidence is lacking (5,6).
The current study, in combination with previous data, is
onsistent with the notion that depressed HF patients may
erceive their QOL to be lower and to underestimate their
unctional status. As discussed in the preceding text, the
nding that younger patients are more depressed, with more dmpaired QOL, suggests that patients’ perceptions of their
ealth status are more important than their absolute phys-
ological impairment in determining both degree of depres-
ion and QOL. This may lead physicians caring for de-
ressed HF patients to classify them as more severely
ompromised and rate their NYHA functional class higher.
f course, it is possible that depressed patients do have
ore advanced HF. It is likely, however, that the combi-
ation of having HF and being depressed has an additive
ffect on worsening the individual’s QOL.
epression and beta-blockade. Although beta-blockers
re commonly thought to cause depression, we found that
epressed patients were actually significantly less likely to be
eceiving beta-blocker therapy. Although this may be ex-
lained by the reluctance of doctors to prescribe beta-
lockers to depressed individuals, it does suggest that
eta-blockers are not likely to cause depression. This is
onsistent with a recent meta-analysis that found no signif-
cant increased risk of depressive symptoms in patients
eceiving beta-blocker therapy (34).
The lower incidence of depression in patients receiving
eta-blockers may also be secondary to beta-blocker-
nduced improvement of HF with consequent perception of
mproved QOL. The present study indicates that the
oncern of the relationship between beta-blockers and
epression is overstated in patients with HF. Depression is
ot a reason to withhold beta-blockers in HF patients.
rediction of depression. The combination of a young age
nd decreased vitality was able to accurately predict depres-
ion in 74% of depressed patients, while falsely predicting
epression in only 27% of patients with a BDI  10. This
s important, as the administration of a depression survey
ay be resisted by patients; physicians may be able to
iagnose depression by specifically evaluating younger pa-
ients with non-threatening and simple vitality questions.
y focusing on relatively young, high-risk patients with
ower vitality, physicians may be able to efficiently identify
atients who could benefit from psychiatric interventions.
linical implications. The data suggest that pharmaco-
ogic or non-pharmacologic treatment of depression could
onceivably reduce morbidity and, perhaps, mortality. A
ecent study evaluated the effect of stress management
raining for patients with HF and found significant im-
rovements in perceived stress, emotional distress, 6-min
alk, and symptoms of depression (35). Treatment of
epression may also help to reduce the medical costs of HF;
retrospective analysis found that, after adjusting for age,
ender, medical co-morbidities, and length of stay at an
ndex hospitalization, costs were significantly higher over a
hree-year period for depressed HF patients than for non-
epressed patients. Increased in-patient and out-patient
tilization contributed to the higher costs (13).
Both depression and congestive HF affect clinical status
n important ways. The additive effect of these conditions
n an individual’s QOL is evident. The best way of treating
epressed HF patients is not known, and certainly other
f
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May 5, 2004:1542–9 Depression in CHFactors might influence which patients will benefit from
arious interventions. Because depression is common in
atients with HF, however, the effects of various anti-
epression strategies should be evaluated.
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